126 related articles for article (PubMed ID: 15297963)
1. Current challenges and opportunities for research on borderline ovarian tumors.
Sherman ME; Berman J; Birrer MJ; Cho KR; Ellenson LH; Gorstein F; Seidman JD
Hum Pathol; 2004 Aug; 35(8):961-70. PubMed ID: 15297963
[TBL] [Abstract][Full Text] [Related]
2. Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives.
Bell DA; Longacre TA; Prat J; Kohn EC; Soslow RA; Ellenson LH; Malpica A; Stoler MH; Kurman RJ
Hum Pathol; 2004 Aug; 35(8):934-48. PubMed ID: 15297961
[TBL] [Abstract][Full Text] [Related]
3. Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior.
Ronnett BM; Kajdacsy-Balla A; Gilks CB; Merino MJ; Silva E; Werness BA; Young RH
Hum Pathol; 2004 Aug; 35(8):949-60. PubMed ID: 15297962
[TBL] [Abstract][Full Text] [Related]
4. [Recent advances in studies of ovarian serous and mucinous borderline ovarien tumors].
Shao HL; Shen DH
Zhonghua Bing Li Xue Za Zhi; 2006 Mar; 35(3):173-5. PubMed ID: 16630508
[No Abstract] [Full Text] [Related]
5. Borderline ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images.
Seidman JD; Soslow RA; Vang R; Berman JJ; Stoler MH; Sherman ME; Oliva E; Kajdacsy-Balla A; Berman DM; Copeland LJ
Hum Pathol; 2004 Aug; 35(8):918-33. PubMed ID: 15297960
[TBL] [Abstract][Full Text] [Related]
6. Serous and mucinous borderline ovarian tumors: are there real differences between these two entities?
Benito V; Lubrano A; Arencibia O; Medina N; Álvarez Eva E; Andújar M; Falcón Juan M; Falcón O
Eur J Obstet Gynecol Reprod Biol; 2010 Dec; 153(2):188-92. PubMed ID: 20728981
[TBL] [Abstract][Full Text] [Related]
7. Current issues in the pathology of ovarian cancer.
Rabban JT; Bell DA
J Reprod Med; 2005 Jun; 50(6):467-74. PubMed ID: 16050571
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
9. TFF3 Expression as Stratification Marker in Borderline Epithelial Tumors of the Ovary.
El-Balat A; Schmeil I; Karn T; Becker S; Sänger N; Holtrich U; Arsenic R
Pathol Oncol Res; 2018 Apr; 24(2):277-282. PubMed ID: 28470574
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and pathological features of borderline ovarian tumors].
Li Y; Cui H; Shen DH; Zhao Y; Wei LH; Qian HN
Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):81-4. PubMed ID: 12783693
[TBL] [Abstract][Full Text] [Related]
11. KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.
Mayr D; Hirschmann A; Löhrs U; Diebold J
Gynecol Oncol; 2006 Dec; 103(3):883-7. PubMed ID: 16806438
[TBL] [Abstract][Full Text] [Related]
12. [Borderline ovarian tumors].
Ivanov S
Akush Ginekol (Sofiia); 2002; 42(1):23-5. PubMed ID: 11935694
[TBL] [Abstract][Full Text] [Related]
13. The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications.
Meinhold-Heerlein I; Fotopoulou C; Harter P; Kurzeder C; Mustea A; Wimberger P; Hauptmann S; Sehouli J
Arch Gynecol Obstet; 2016 Apr; 293(4):695-700. PubMed ID: 26894303
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis of ovarian tumors by sonography].
Wu ZY; Zhang GY; Du ZB
Zhonghua Fu Chan Ke Za Zhi; 1994 Feb; 29(2):100-2, 125. PubMed ID: 8033625
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathologic features of 234 cases with borderline ovarian tumors].
Ren J; Lou JY; Liu H; Wang P; Zhang JW; Yang KX; Wang HJ; Qie MR; Peng ZL
Zhonghua Fu Chan Ke Za Zhi; 2009 Feb; 44(2):116-20. PubMed ID: 19570422
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of two groups of patients with serous and mucinous types of borderline ovarian tumors].
Makarewicz H; Emerich J; Olszewski J
Ginekol Pol; 2003 Jan; 74(1):24-31. PubMed ID: 12715434
[TBL] [Abstract][Full Text] [Related]
17. [Accuracy of frozen section in diagnosis of ovarian tumors].
Zhang GN
Zhonghua Fu Chan Ke Za Zhi; 1993 Oct; 28(10):601-3, 635. PubMed ID: 8112130
[TBL] [Abstract][Full Text] [Related]
18. Histological classification of ovarian cancer.
Kaku T; Ogawa S; Kawano Y; Ohishi Y; Kobayashi H; Hirakawa T; Nakano H
Med Electron Microsc; 2003 Mar; 36(1):9-17. PubMed ID: 12658347
[TBL] [Abstract][Full Text] [Related]
19. Borderline ovarian tumors: key points and workshop summary.
Silverberg SG; Bell DA; Kurman RJ; Seidman JD; Prat J; Ronnett BM; Copeland L; Silva E; Gorstein F; Young RH
Hum Pathol; 2004 Aug; 35(8):910-7. PubMed ID: 15297959
[TBL] [Abstract][Full Text] [Related]
20. [Clinical characteristics of borderline ovarian tumors and stage I epithelial ovarian cancer: an analysis of 143 cases].
Zhao Y; Wang Y; Shen Dh; Song Rn; Xu Q; Li Y; Cui H; Tang J; Wei Lh
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Feb; 43(1):123-8. PubMed ID: 21321635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
